Puma Biotechnology Announces Amendment to Neratinib Licensing Agreement[...]
Puma Biotechnology Announces Positive Top Line Results from Phase III[...]
Puma Biotechnology Reports Second Quarter 2014 Financial Results
05/07/2024 | Press release | Distributed by Public on 05/07/2024 06:56
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM N-MFP MONTHLY SCHEDULE OF PORTFOLIO HOLDINGS OF MONEY MARKET FUNDS |
Please select the service you want to use:
Smartlinks | HSBC Funds | News | Health | Finance | Security Markets | Security Markets | Company News | Financial Services | Investment Funds | Investment Services | Private Companies | Investment Management Companies
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact